LRIG1 Antibodies

Santa Cruz Biotechnology features a diverse variety of LRIG1 monoclonal antibodies for research focused on understanding LRIG1 protein function. LRIG1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LRIG1, or leucine-rich repeats and immunoglobulin-like domains 1, functions as a key regulator of receptor tyrosine kinases and influences cell signaling pathways that control cell growth and differentiation. LRIG1 has emerged as an important focus in cancer research due to its role in tumor suppression and modulation of cellular responses to growth factors. Research involving LRIG1 continues to reveal new insights into various pathological conditions. Understanding LRIG1 dynamics can lead to innovative therapeutic approaches. Investigating LRIG1 expression and activity patterns helps researchers uncover its complex biological functions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of LRIG1's role in health and disease.